Could a single cell infusion free liver transplant patients from lifelong drugs?
NCT ID NCT03164265
First seen Oct 01, 2025 · Last updated May 13, 2026 · Updated 30 times
Summary
This study tested whether giving liver transplant patients a special immune cell infusion before surgery could help them safely stop taking anti-rejection drugs. Sixteen low-risk patients received the infusion and were slowly weaned off their medications over a year if they met certain criteria. The goal was to see if the body could accept the new liver without long-term drugs, but patients who succeeded still needed monitoring for three years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVING DONOR LIVER TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UPMC
Pittsburgh, Pennsylvania, 15261, United States
Conditions
Explore the condition pages connected to this study.